Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adverum Biotechnlgs (NQ: ADVM )

8.860 USD -0.540 (-5.74%)
Official Closing Price Updated: 5:49 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Adverum Biotechnlgs

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET Friday, 62 stocks made new 52-week lows. Significant Points: The largest company by ... 
Tags EXTN STG APRE
From Benzinga
Adverum Biotechnologies to Present New Data from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at ARVO 2021
From GlobeNewswire News Releases
Adverum Files Definitive Proxy Materials and Mails Letter to Stockholders Detailing Strength of Team and Acceleration Toward Commercialization of ADVM-022
From GlobeNewswire News Releases
The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SYRS NTUS Penny Stocks
From Benzinga
The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags JNJ TIL DSGN
From Benzinga
Stocks That Hit 52-Week Lows On Monday
Before 10 a.m. ET on Monday, 30 stocks hit new 52-week lows. Interesting Highlights: The largest company by market ... 
Tags VSTA CALA IONS
From Benzinga
The Sonic Fund II, L.P. Files Preliminary Proxy Statement Relating to the Election of Highly Qualified Independent Directors at the 2021 Annual Meeting of Adverum Biotechnologies, Inc.
Issues Important Note to Shareholders to Ensure Shares Are Voteable at the 2021 Annual Meeting 
From PR Newswire
Analysts Predict 10% Gains Ahead For The Holdings of KOMP
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Adverum Announces Senior Appointments for Patient Access and Clinical Operations as ADVM-022 Advances Toward Global Phase 3 Trials
From GlobeNewswire News Releases
Friday 3/26 Insider Buying Report: ADVM, AFCG
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. 
Tags Stocks
From Market News Video
Adverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FOLD ANGO RDHL
From Benzinga
Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value Creation
From GlobeNewswire News Releases
Noteworthy Friday Option Activity: T, ADVM, SWKS
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in AT&T Inc (T), where a total volume of 196,187 contracts has been traded thus far... 
Tags Stocks
From Market News Video
ADVM Trading Below Director's Recent Buy Price
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on January 15, Adverum Biotechnologies Inc's Director,... 
Tags Stocks
From Market News Video
Analysts Predict 11% Upside For The Holdings of MOON
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Adverum Biotechnologies, Inc. (ADVM) Q4 2020 Earnings Call Transcript
ADVM earnings call for the period ending December 31, 2020. 
Tags Market News ADVM
From Motley Fool
Adverum Announces Shortened Timelines and Clear Development Path for ADVM-022 Intravitreal Gene Therapy in Wet AMD, Reports Recent Business Progress and Fourth Quarter 2020 Financial Results
From GlobeNewswire News Releases
Earnings Scheduled For March 1, 2021
Companies Reporting Before The Bell • Athenex (NASDAQ:ATNX) is likely to report quarterly loss at $0.44 per share on ... 
Tags MORF FSKR INSG
From Benzinga
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and ... 
Tags EYPT ATRA SBBP
From Benzinga
Adverum to Host Conference Call and Webcast to Highlight Updated ADVM-022 Development Plans in Wet AMD, Recent Business Progress, and Fourth Quarter 2020 Financial Results
Key Opinion Leader Arshad M. Khanani, M.D., M.A., director of clinical research, Sierra Eye Associates, and OPTIC and INFINITY trial investigator will participate on this call 
From GlobeNewswire News Releases
Adverum Appoints Esteemed Healthcare Executive Reed V. Tuckson, M.D., to Board of Directors
From GlobeNewswire News Releases
Adverum Appoints Christopher J. DeRespino as Chief Business Officer
From GlobeNewswire News Releases
Adverum to Present Data from the OPTIC Phase 1 Trial with ADVM-022 Intravitreal Gene Therapy in Wet AMD at the Angiogenesis, Exudation, and Degeneration 2021 Virtual Meeting
From GlobeNewswire News Releases
Adverum Biotechnologies Announces Publication of Preclinical Long-Term Safety Data on ADVM-022 IVT Gene Therapy
-- Long-term safety and sustained anti-VEGF protein expression out to 30 months following a single IVT injection of ADVM-022 in NHPs -- 
From GlobeNewswire News Releases
Implied XBI Analyst Target Price: $205
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Notable Insider Buys Of The Past Week: Affirm, HEICO, Vector Group, Biotechs, And More
Insider buying can be an encouraging signal for investors, particularly when there is uncertainty in the markets. With earnings reporting season in full swing, buy windows for many insiders are... 
Tags Stocks / Equities
From Blogs - TalkMarkets
Notable Insider Buys Of The Past Week: Affirm, HEICO, Vector Group, Biotechs And More
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Insiders have been ... 
Tags Benzinga Owens & Minor WOOF
From Benzinga
68 Biggest Movers From Yesterday
Gainers Obalon Therapeutics Inc (NASDAQ: OBLN) shares jumped 414.3% to close at $8.28 on Wednesday after the company announced a ... 
Tags DARE DMYD Benzinga
From Benzinga
45 Stocks Moving In Wednesday's Mid-Day Session
Gainers Obalon Therapeutics Inc (NASDAQ: OBLN) shares jumped 175% to $4.4250 after the company announced a merger agreement with ... 
Tags SNCR Trading Ideas Intraday Update
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.